Triple Therapy with Garlic, Silymarin and Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled Clinical Trial
Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. We aimed to evaluate the effect of a mixture of garlic, silymarin, and curcumin on hepatic parameters and overall improvement of NAFLD. Materials and Methods: Individuals between 18 and 70 ye...
Saved in:
Main Authors: | Zahra Ataee (Author), Maryam Vahabzadeh (Author), Seyedeh Shabnam Mazloumi Kiapey (Author), Hamid Reza Rahimi (Author), Hooman Mosanan Mozaffari (Author), Maliheh Ziaee * (Author) |
---|---|
Format: | Book |
Published: |
Lorestan University of Medical Sciences,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Silymarin on Gentamicin-Induced Nephrotoxicity in Infectious Patients: A Randomized Double Blinded Placebo-Controlled Clinical Trial
by: Motahareh Mahi-birjand, et al.
Published: (2020) -
The comparison of the effects of nano-silymarin and silymarin on high-fat diet-induced fatty liver of adult male rats
by: Reza Mohebbati, et al.
Published: (2024) -
Hepatoprotective Effects of Curcumin Nanomicells in Alcohol-induced Liver Injury: Comparison with Curcumin and Silymarin in Mice Model
by: Faezeh Maghsoumi, et al.
Published: (2019) -
The effect of silymarin on non-alcoholic fatty liver disease of children
by: Fatemeh Famouri, et al.
Published: (2017) -
The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial
by: Safoora Sadat Erfanian, et al.
Published: (2024)